Trials / Completed
CompletedNCT00131326
A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Synvisc (hylan G-F 20) |
Timeline
- Start date
- 2003-11-01
- Completion
- 2006-04-01
- First posted
- 2005-08-18
- Last updated
- 2017-07-31
Locations
32 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00131326. Inclusion in this directory is not an endorsement.